Iteos Therapeutics Inc (ITOS) — Financial Flexibility Index
Iteos Therapeutics Inc (ITOS) has a Financial Flexibility Index of -0.33x as of June 2025. Free cash flow of $-42.16 Million (operating CF $-42.45 Million minus capex $283.00K) represents 0% of total liabilities ($129.28 Million). Check ITOS capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Iteos Therapeutics Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Iteos Therapeutics Inc across 7 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Iteos Therapeutics Inc.
Annual Financial Flexibility Index for Iteos Therapeutics Inc (2018–2024)
Year-by-year free cash flow to debt coverage for Iteos Therapeutics Inc. Explore Iteos Therapeutics Inc (ITOS) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.00x | $-96.55 Million | $-98.18 Million | $96.68 Million | ▲ +8.5% |
| 2023 | -1.09x | $-100.79 Million | $-103.76 Million | $92.36 Million | ▲ +9.3% |
| 2022 | -1.20x | $-110.25 Million | $-111.19 Million | $91.66 Million | ▼ -177.6% |
| 2021 | 1.55x | $514.32 Million | $513.14 Million | $331.89 Million | ▲ +233.4% |
| 2020 | -1.16x | $-24.82 Million | $-25.18 Million | $21.36 Million | ▲ +21.9% |
| 2019 | -1.49x | $-22.42 Million | $-23.14 Million | $15.07 Million | ▲ +2.7% |
| 2018 | -1.53x | $-18.87 Million | $-19.10 Million | $12.34 Million | — |